1 / 28

Virtual Screening with Topomer CoMFA

Virtual Screening with Topomer CoMFA. Dick Cramer “Brave New World of QSAR”, ACS August 19, 2002. Outline. Topomers (similarity searching) Method and strengths Prospective “lead-hopping” results Topomer CoMFA Methodology Retrospective computational validation Prospective results.

aleda
Download Presentation

Virtual Screening with Topomer CoMFA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Virtual Screening with Topomer CoMFA Dick Cramer “Brave New World of QSAR”, ACS August 19, 2002

  2. Outline • Topomers (similarity searching) • Method and strengths • Prospective “lead-hopping” results • Topomer CoMFA • Methodology • Retrospective computational validation • Prospective results

  3. Seeking and Developing “Islands of Activity” in “Chemistry Space” • “Lead Discovery” = find land • “Lead Explosion” = define and claim island • “Lead Hopping” = find another island • “Lead Optimization” = find high enough peak • But, instead of the two latitude / longitude dimensions of geographical exploration, there are an exponentially enormous number of ways to describe “chemistry space”. • Poor descriptions destroy islands (MW) • Topomers provide an excellent “compass” for drug discovery B-lactams ACE Inhibitors H2 blockers

  4. Topomers are novel 3D models • Only fragments have topomers! • Whole similarity = sum-of-fragment similarities • How topomers handle 3D • Structures oriented • Overlay of open valences • Single conformer • CONCORD 3D structures • Side-chain & chiral via rules • Topomer similarity is in: • Steric fields (as in CoMFA) • Binned values • Rot.bond-attenuated atomic fields • Feature matching (as in conventional 3D searching) • 1999 Tripos, Inc.

  5. A B C D * Generating a Topomer attachment bond chiral atom free valence A => B: Attach “anchor group”; generate 3D model; overlap attachment bond B => C: starting at attachment bond: adjust chirality select torsion end-points and adjust dihedral angles

  6. Topomer Searching in Drug Discovery: Summary • Many distinct advantages • Speed, to address the vastness of chemistry space* (1000’s of ‘CAS units’ per second!) • Has yet to fail in identifying promising and patentable biological activity • Novelty of hits • Accessibility of hits • Physical interpretability of model • Exists in either of two flavors • ChemSpace (virtual libraries ~1013) • dbtop (conventional collections ~106) • No plans exist for distributing either flavor *when searching virtual libraries (ChemSpace)

  7. Why topomer searching is so fast R3: ordered by sorted topomer distance Vast Virtual Library R2: ordered by sorted topomer distance R1: ordered by sorted topomer distance

  8. Discovery projects using topomer-similarity-driven “Lead-Hopping” • Arena (structure originally found is still the lead) • BMS (published validation, see references) • Lipha (seven lead hop trials, five successes) • LeadQuest screening (partially disclosable)

  9. Recent prospective topomer similarity results • 7 query structures having different activities chosen from recent patents (WD Alert) • 257 topomerically most (but not very) similar structures among 80K LeadQuest cpds (80K/(257/7) = 0.05%) were selected (by dbtop) and tested @10 or 100 um • Screening:, >50% 37 (14%). >30%: 56 (22%) • IC50’s: 25 cpds < 30 um, for 5 of 7 query structures • Active structures are clear “lead hops” (only 1 homologue) (active structures are being followed up and so currently may be viewed only upon execution of a CDA) queries actives found

  10. The Paradoxical Limitation of Similarity Selection Receptor • As similarity to an active • compound decreases: • activity usually decreases • but sometimes increases Similarity selection => change is bad BUT ... Successful lead optimization (um => nm potency) requires changes that help! Such changes are discovered by (Q)SAR

  11. CoMFA is a (3D-Q)SAR method.quickly, how does it work? Contour Maps Predictions PLS Bio QSAR equation QSAR Table = SYBYL MSS

  12. Pros and Cons of CoMFA(a leading (3D-Q)SAR method) • Advantages of CoMFA • very generally applicable • robust, widely used and accepted • models easy to understand, interpret • excellent record for predicting potency • Disadvantages of CoMFA • Input: “alignment” of 3D models is ill-defined • Output: does not select, only predicts

  13. Topomeric CoMFA: a neat complementarity • Can we perform successful CoMFAs based on (automatic / ignorant) topomer aligment rules? • Yes! (surprisingly) • the CoMFA input bottleneck is thereby broken • Can we use the resulting CoMFA SARs to search for more active structures? • the CoMFA (QSAR) output bottleneck disappears • topomer searching becomes very useful in lead optimization

  14. Implementing Topomeric CoMFA • Input molecules must be fragmented • each fragment set gets its own CoMFA column • data sets fall into four different classes:

  15. Validating Topomeric CoMFA: Methodology • How do topomeric alignments perform, compared to successful CoMFA alignments from literature? • 10 recent CoMFA pubs => 14 end points (+1 alternative topomer fragmentation) == 15 trials • Literature alignments: 8/15 used X-ray • Data sets: 6 Class 1 (3-piece), 9 Class 2 (2-piece)

  16. Example Topomer Alignment:2 piece (5ht3) (61 structures: orthogonal views) X2 (.680 of model) X1 (.320 of model)

  17. Validating Topomeric CoMFA:Remarkably Good Results Satisfactory results obtained in each of the 15 trials Average performance of automatic topomer alignments almost identical to literature alignments: aUsing standard CoMFA fields and methods bUsing “topomeric CoMFA fields”. #comp from xval SDEV min, not q2 max cOmission of one data set having suspect predictions

  18. Why do context-ignorant topomer alignments perform so well? • 15 successes in 15 trials is not just good luck • Topomer alignments do align “like with like” • Context-knowledgable (literature) alignment must be introducing as much noise as signal • Example: docking of combi (common core) libraries: Docking moves the core around, producing field variation that is noise, because .. ..an invariant core cannot cause changes in biological activity

  19. What about Topomer CoMFA Searching? • Topomer rules are structurally universal • Directly search VL’s (ChemSpace) • Directly search conventional DB’s (dbtop) for fragments • Search objectives (to be “and’d” together): • Similarity to average of CoMFA input fields • Predicted high potency • Exploration of new regions (happens automatically) • Required development of • Binned electrostatic fields for all stored topomers • Extracting “features” from CoMFA input structures

  20. Examples of Topomer CoMFA Searching results • For each of the 15 validation data sets • Searched “2-piece” CS libraries in use (~108 structures) • derived from commercially offered (readily accessible) reagents • “best CoMFA Inputs” == R’s in most active CoMFA input • “best Searching Hits” == R‘s with highest predicted potency contribution (+ < 150 similarity + synthetically tractable) • Shown for both “best R’s” are • 2D structures with potency contributions • 3D topomer structures overlaid on CoMFA grid (orthogonal views) • In 13 of the 15 cases, best “Searching Hits” .. • together exceed best experimental potency by >1.0 log units

  21. Topomer CoMFA Searching Hits (5ht3) Best CoMFA Input Best Searching Hits Site 1: Potency effect (similarity) +1.2 (106) +0.8 Site 2: Potency effect (similarity) +1.8 +2.5 (112)

  22. CoMFA Input vs. Best Hit in 3D (5ht3_1) Input example Best Hit

  23. CoMFA Input vs. Best Hit in 3D (5ht3_2) Input example Best Hit

  24. Three Prospective Applications of Topomer CoMFA • Good topomer CoMFA models automatically obtained in 3/3 trials (two projects) • Prediction of potencies satisfactory in 2/3 trials (predicted/active r2 of .42 and .24) • Difficulty with third unsatisfactory trial was: little variation among potency predictions, because of • Little structural variety in training set, &/or • Test set variation irrelevant to training set variation • Errors of prediction are “false positives” much more often than “false negatives”

  25. Topomer CoMFA (Searching):Conclusions • Automatic CoMFA alignments are a reality • lit. alignments => topomer alignments … 15 / 15 times • 2D structures to finished CoMFA takes a few minutes • Topomeric alignments enable topomer searching • For improved potency as well as similarity within the vast search space accessible to topomers • Novelty of hits seems self-evident • New “receptor space” is being “targeted” • Promises a uniquely powerful engine for lead optimization ... • Initial applications confirm promise

  26. Design / Implementation Katherine Andrews-Cramer Rob Jilek Use and Feedback Stefan Guessregen Mark Warne Katherine Andrews-Cramer Acknowledgments Dbtop (WDA queries) • Topomer CoMFA • Use and Feedback • Bernd Wendt • Mike Lawless

  27. References • Cramer, R. D.; Clark, R. D.; Patterson, D. E.; Ferguson, A. M. Bioisosterism as a molecular diversity descriptor: steric fields of single topomeric conformers. J. Med. Chem. 1996, 39, 3060-3069. • Patterson, D. E.; Cramer, R. D.; Ferguson, A. M.; Clark, R. D.; Weinberger, L. E. Neighborhood behavior: a useful concept for validation of molecular diversity descriptors. J. Med. Chem. 1996, 39, 3049-30 • Cramer, R. D.; Patterson, D. E.; Clark, R. D.; Soltanshahi, F.; Lawless, M. S. Virtual libraries: a new approach to decision making in molecular discovery research. J. Chem. Inf. Comp. Sci. 1998, 6, 1010-1023. • Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective Identification of Biologically Active Structures by Topomer Shape Similarity Searching. J. Med. Chem. 1999, 42, 3919-3933. • Andrews, K. M.; Cramer, R. D. Toward General Methods of Targeted Library Design: Topomer Shape Similarity Searching with Diverse Structures as Queries, J. Med. Chem, J. Med. Chem. 2000, 43, 1723-1740. • Cramer, R. D.; Jilek, R. J.; Andrews, K. M. dbtop: Topomer Similarity Searching of Conventional Databases, J. Mol. Graph. Modeling 2002, 20, 447-462. • Cramer, R.D. Topomer CoMFA: A Design Methodology for Rapid Lead Optimization, J. Med. Chem., manuscript accepted.

More Related